Approval · Notice of Compliance 14093 · 2013
MOTRIN: Notice of Compliance 14093
Issued February 14, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14093
- Date
- February 14, 2013
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Therapeutic class
- Analgesic; antipyretic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MOTRIN | 02186934 | Marketed |
| MOTRIN | 02242632 | Marketed |
| MOTRIN | 02242658 | Marketed |
| MOTRIN LIQUID GELS 200 MG | 02297582 | Marketed |
| MOTRIN GELCAPS | 01983873 | Cancelled Post Market |
| MOTRIN CAPLET | 02187124 | Cancelled Post Market |